| Orladeyo 150 mg hard capsules EU/1/21/1544/001 |
Berotralstat hydrochloride, Berotralstat |
BioCryst Ireland Ltd |
— |
| Orphacol 250 mg hard capsules EU/1/13/870/004-006 |
Cholic acid |
Theravia |
— |
| Orphacol 50 mg hard capsules EU/1/13/870/001-003 |
Cholic acid |
Theravia |
— |
| ORSERDU 345 mg film-coated tablets EU/1/23/1757/002 |
Elacestrant Dihydrochloride |
Stemline Therapeutics B.V. |
— |
| ORSERDU 86 mg film-coated tablets EU/1/23/1757/001 |
Elacestrant Dihydrochloride |
Stemline Therapeutics B.V. |
— |
| Osenvelt 120 mg solution for injection EU/1/24/1904/001-003 |
Denosumab |
Celltrion Healthcare Hungary Kft. |
— |
| Oslif Breezhaler 150 microgram inhalation powder, hard capsules EU/1/09/586/1-5 |
Indacaterol maleate |
Novartis Europharm Limited |
— |
| Oslif Breezhaler 300 microgram inhalation powder, hard capsules EU/1/09/586/6-10 |
Indacaterol maleate |
Novartis Europharm Limited |
— |
| Osmohale, inhalation powder, hard capsule PA22655/001/001 |
Mannitol |
Pharmaxis Europe Limited |
Marketed |
| Osvyrti 60mg Solution for injection in pre-filled syringe EU/1/25/1922/002 |
Denosumab |
Accord Healthcare S.L.U. |
— |
| Otezla 10 mg film-coated tablets Otezla 20 mg film-coated tablets EU/1/14/981/004 |
Apremilast, Apremilast |
Amgen Europe B.V., |
— |
| Otezla 10 mg film-coated tablets Otezla 20 mg film-coated tablets Otezla 30 mg film-coated tablets EU/1/14/981/001 |
Apremilast, Apremilast, Apremilast |
Amgen Europe B.V., |
— |
| Otezla 20 mg film–coated tablets EU/1/14/981/005 |
Apremilast |
Amgen Europe B.V., |
— |
| Otezla 30 mg film-coated tablets EU/1/14/981/002-003 |
Apremilast |
Amgen Europe B.V., |
— |
| Otulfi 130 mg Concentrate for solution for infusion EU/1/24/1863/003 |
Ustekinumab |
Fresenius Kabi Deutschland GmbH |
— |
| Otulfi 45 mg Solution for injection EU/1/24/1863/001 |
Ustekinumab |
Fresenius Kabi Deutschland GmbH |
— |
| Otulfi 45 mg Solution for injection pre-filled pen EU/1/24/1863/005 |
Ustekinumab |
Fresenius Kabi Deutschland GmbH |
— |
| Otulfi 90 mg Solution for injection EU/1/24/1863/002 |
Ustekinumab |
Fresenius Kabi Deutschland GmbH |
— |
| Otulfi 90 mg Solution for injection in Pre-filled pen EU/1/24/1863/006 |
Ustekinumab |
Fresenius Kabi Deutschland GmbH |
— |
| Ovaleap 300 IU/0.5 mL solution for injection EU/1/13/871/001-003 |
Follitropin alfa |
Theramex Ireland Limited |
— |
| Ovitrelle 250 micrograms solution for injection in pre-filled pen EU/1/00/165/008 |
Choriogonadotropin alfa |
Merck Europe B.V. |
— |
| Ovitrelle 250 micrograms/0.5 mL solution for injection in pre-filled syringe EU/1/00/165/007 |
Choriogonadotropin alfa |
Ares-Serono (Europe) Limited |
— |
| Oxaliplatin 5 mg/ml concentrate for solution for infusion PA2059/049/001 |
Oxaliplatin |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Oxbryta EU/1/21/1622/001 |
Voxelotor |
Pfizer Europe MA EEIG |
— |
| OXERVATE 20 micrograms/ml eye drops, solution EU/1/17/1197/01 |
Recombinant human nerve growth factor (rhngf) |
Dompe farmaceutici SpA |
— |
| Oxlumo 94.5 mg/0.5 mL solution for injection EU/1/20/1496/001 |
Lumasiran sodium |
Alnylam Netherlands B.V. |
— |
| OxyContin 10 mg prolonged release tablets PA1688/005/002 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyContin 20 mg prolonged release tablets PA1688/005/003 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyContin 40 mg prolonged release tablets PA1688/005/004 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyContin 5 mg prolonged release tablets PA1688/005/001 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyContin 80 mg prolonged release tablets PA1688/005/005 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Not marketed |
| OxyNorm 10 mg hard capsules PA1688/006/005 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyNorm 10 mg/ml, solution for injection or infusion PA1688/006/001 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyNorm 20 mg hard capsules PA1688/006/006 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyNorm 5 mg hard capsules PA1688/006/004 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyNorm 50 mg/ml, solution for injection or infusion PA1688/006/010 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyNorm concentrate 10 mg/ml oral solution PA1688/006/003 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyNorm Dispersa 10 mg Orodispersible Tablets PA1688/006/008 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyNorm Dispersa 20 mg orodispersible tablets PA1688/006/009 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyNorm Dispersa 5 mg Orodispersible Tablets PA1688/006/007 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| OxyNorm liquid 1 mg/ml oral solution PA1688/006/002 |
OXYCODONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Oyavas 25 mg/mL concentrate for solution for infusion EU/1/20/1510/001-002 |
Bevacizumab |
Stada Arzneimittel AG |
— |
| Ozawade 18 mg film-coated tablets EU/1/21/1546/002-003 |
Pitolisant hydrochloride |
Bioprojet Pharma |
— |
| Ozawade 4.5 mg film-coated tablets EU/1/21/1546/001 |
Pitolisant hydrochloride |
Bioprojet Pharma |
— |
| Ozempic 0.25 mg solution for injection in pre-filled pen EU/1/17/1251/002 |
Semaglutide |
Novo Nordisk A/S |
— |
| Ozempic 0.5 mg solution for injection in pre-filled pen EU/1/17/1251/003-004 |
Semaglutide |
Novo Nordisk A/S |
— |
| Ozempic 0.5 mg solution for injection in pre-filled pen EU/1/17/1251/012-013 |
Semaglutide |
Novo Nordisk A/S |
— |
| Ozempic 1 mg solution for injection in pre-filled pen EU/1/17/1251/005-006 |
Semaglutide |
Novo Nordisk A/S |
— |
| Ozempic 2 mg solution for injection in pre-filled pen EU/1/17/1251/010-011 |
Semaglutide |
Novo Nordisk A/S |
— |
| OZURDEX 700 micrograms intravitreal implant in applicator EU/1/10/638/001 |
Dexamethasone |
AbbVie Deutschland GmbH & Co. KG |
— |